Nucleic Acids Research, 1993, Vol. 21, No. 25 6020-6027
© 1993
MOLECULAR BIOLOGY |
Correlation between the presence of a self-splicing intron in the 25S rDNA of C.albicans and strains susceptibility to 5-fluorocytosine
De`partement de Microbiologie et Immunologie, Faculte` de Medecine, Universite` de Montre`al CP 6128, Succ. A, Montre`al, Quebec H3C 3J7, Canada
To whom correspondence should be addressed
Received July 30, 1993. Revised November 19, 1993. Accepted November 19, 1993.
Candida albicans presents a well characterized EcoRI RFLP pattern of intensely staining bands. One of these bands, the dimorphic 3.7/4.2 kbp fragment shown to originate from the ribosomal RNA-encoding regions (rDNA), has been used by several investigators to subdivide C.albicans strains in two distinct subtypes. In the present manuscript, we report that an epidemiological study of 120 C.albicans strains revealed a significant correlation between these subtypes and susceptibility to 5-fluorocytosine, an antifungal agent extensively used for biotyping C.albicans. The 4.2 kbp strains being generally more susceptible than their counterparts to this agent and one of its metabolic by-product, 5-fluorouracil. A 379 nucleotides insertion in the 25S rRNA-encoding gene of 4.2 kbp type strains was shown to be responsible for the 3.7/4.2 size difference. This intervening sequence is typical of a group I intron by its site of insertion, its predicted secondary structure, and its self-splicing capability. Assuming there is a genuine causal relationship between presence of the intron and resistance to 5-fluorocytosine, one possible mechanism suggests that inhibition of self-splicing by the insertion of 5-fluorouracil residues in the 25S rRNA precursor might be responsible for the higher susceptibility of 4.2 kbp type strains.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Li and Y. Zhang Predicting the secondary structures and tertiary interactions of 211 group I introns in IE subgroup Nucleic Acids Res., April 20, 2005; 33(7): 2118 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Disney, R. Stephenson, T. W. Wright, C. G. Haidaris, D. H. Turner, and F. Gigliotti Activity of Hoechst 33258 against Pneumocystis carinii f. sp. muris, Candida albicans, and Candida dubliniensis Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1326 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pujol, M. A. Pfaller, and D. R. Soll Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans Antimicrob. Agents Chemother., January 1, 2004; 48(1): 262 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Xiao, M. J. Leibowitz, and Y. Zhang Concerted folding of a Candida ribozyme into the catalytically active structure posterior to a rapid RNA compaction Nucleic Acids Res., July 15, 2003; 31(14): 3901 - 3908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Childs, M. D. Disney, and D. H. Turner Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing PNAS, August 20, 2002; 99(17): 11091 - 11096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Stevens Molecular Epidemiology of Candida J. Clin. Microbiol., July 1, 2002; 40(7): 2710 - 2710. [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, Z. Li, D. S. Pilch, and M. J. Leibowitz Pentamidine inhibits catalytic activity of group I intron Ca.LSU by altering RNA folding Nucleic Acids Res., July 1, 2002; 30(13): 2961 - 2971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tamura, K. Watanabe, Y. Mikami, K. Yazawa, and K. Nishimura Molecular Characterization of New Clinical Isolates of Candida albicans and C. dubliniensis in Japan: Analysis Reveals a New Genotype of C. albicans with Group I Intron J. Clin. Microbiol., December 1, 2001; 39(12): 4309 - 4315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang and M. J. Leibowitz Folding of the group I intron ribozyme from the 26S rRNA gene of Candida albicans Nucleic Acids Res., June 15, 2001; 29(12): 2644 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Lott and M. M. Effat Evidence for a more recently evolved clade within a Candida albicans North American population Microbiology, June 1, 2001; 147(6): 1687 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Biswas, K. Yokoyama, L. Wang, K. Nishimura, and M. Miyaji Typing of Candida albicans Isolates by Sequence Analysis of the Cytochrome b Gene and Differentiation from Candida stellatoidea J. Clin. Microbiol., April 1, 2001; 39(4): 1600 - 1603. [Abstract] [Full Text]
|
|
|
|
|
|
K. E. Miletti and M. J. Leibowitz Pentamidine Inhibition of Group I Intron Splicing in Candida albicans Correlates with Growth Inhibition Antimicrob. Agents Chemother., April 1, 2000; 44(4): 958 - 966. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. R. Soll The Ins and Outs of DNA Fingerprinting the Infectious Fungi Clin. Microbiol. Rev., April 1, 2000; 13(2): 332 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Testa, S. M. Gryaznov, and D. H. Turner In vitro suicide inhibition of self-splicing of a group I intron from Pneumocystis carinii by an N3' right-arrow P5' phosphoramidate hexanucleotide PNAS, March 16, 1999; 96(6): 2734 - 2739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. McCullough, K. V. Clemons, and D. A. Stevens Molecular and Phenotypic Characterization of Genotypic Candida albicans Subgroups and Comparison with Candida dubliniensis and Candida stellatoidea J. Clin. Microbiol., February 1, 1999; 37(2): 417 - 421. [Abstract] [Full Text]
|
|